LOS ANGELES, CA--(Marketwire - Feb 13, 2012) - Fresh Start Private Management Inc. (OTCBB: [ CEYY ]), a leader in alcohol treatment and rehabilitation, is pleased to announce that it has completed the sale of a licensing agreement with Glacier Holdings, LLC, (Glacier) for the rights to Florida.

The license agreement provides Glacier the rights to use the highly effective implant that delivers targeted therapeutic levels of Naltrexone, significantly reducing patients' cravings for alcohol. Glacier also will be incorporating the Fresh Start's exclusive Life Coaching rehabilitation program.

Managing Member of Glacier, Tim Jackoboice, will operate the new facility under the Fresh Start Private Florida, LLC brand and will serve as the company's CEO.

Mr. Jackoboice graduated with a degree in Economics from the University of Arizona in Tucson, Arizona. He most recently held positions as director, officer and owner of Monarch Hydraulics in Grand Rapids, Michigan, and with institutional traders on the Floor of the New York Stock Exchange. He is also the Founder and CEO at KeyRingThing LLC.

"We are very pleased to welcome Mr. Jackoboice to the Fresh Start brand. His extensive background and business knowledge will be a great addition in the State of Florida. We are eager for the new facility to be open, making the Fresh Start program available to potentially thousands of patients in the Florida area," commented Neil Muller, President.

About Fresh Start Private
Fresh Start Private is an alcohol addiction, alcohol withdrawal, alcohol abuse treatment and alcohol detox rehabilitation company on the leading edge of alcohol addiction treatment. The Company has licensed a highly effective treatment that delivers target therapeutic levels of Naltrexone that significantly reduce patients' cravings for alcohol. Please visit [ www.freshstartprivate.com ].

Safe Harbor
The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. These forward-looking statements, specifically statements relating to expectations regarding commercial viability of it products and services well involve risks and uncertainties that include, among others, fluctuations in third party pricing and services; the timely receipt of necessary permits and approvals; market demand for, and/or available supplies of, alcohol treatment related products and services; unanticipated delays, risks related to competition, management of growth, new products, services and technologies, potential fluctuations in operating results, international expansion, commercial agreements, acquisitions and strategic transactions, government regulation and taxation. You should carefully review the information disclosed within the section entitled "Risk Factors" contained in the Company's Current Report on Form 8K filed on November 4, 2011, as well as the information contained in this release, when assessing the Company and its business. The Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.